676559-83-4

Basic information

• Product Name: ABT-279
• Synonyms: ABT-279;2-[4-[[2-[(2S,5R)-2-Cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]-4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid;FIMRNLAKAARHPD-IRXDYDNUSA-N
• CAS NO: 676559-83-4
• Molecular Formula: C21H25N5O3
• Molecular Weight: 395.4549
• Mol File: 676559-83-4.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Density: 1.32
• CAS DataBase Reference: ABT-279(CAS DataBase Reference)
• NIST Chemistry Reference: ABT-279(676559-83-4)
• EPA Substance Registry System: ABT-279(676559-83-4)

Safety Data

• Hazardous Substances Data: 676559-83-4(Hazardous Substances Data)

Usage

General Description

ABT-279 is a drug compound developed by Abbott Laboratories that acts as a potent and selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH). This enzyme is responsible for breaking down endocannabinoids in the body, which play a role in regulating pain, mood, and appetite. By inhibiting FAAH, ABT-279 increases the levels of endocannabinoids, leading to potential therapeutic effects in the treatment of pain, anxiety, and inflammation. ABT-279 has shown promising results in preclinical studies, and further research is underway to explore its potential as a treatment for various medical conditions.